We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+33.48%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$611M
AUM Growth
+$11.7M
Cap. Flow
-$91.9M
Cap. Flow %
-15.04%
Top 10 Hldgs %
4.77%
Holding
1,794
New
573
Increased
263
Reduced
313
Closed
643

Top Buys

Rank Stock Value
1
BBY icon
Best Buy
BBY
+$2.79M
2
BBWI icon
Bath & Body Works
BBWI
+$2.78M
3
AMD icon
Advanced Micro Devices
AMD
+$2.7M
4
NVDA icon
NVIDIA
NVDA
+$2.4M
5
XOM icon
ExxonMobil
XOM
+$2.28M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.42%
2 Technology 16.02%
3 Healthcare 14.17%
4 Industrials 13.83%
5 Financials 11.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BX icon
976
Blackstone
BX
$110B
$204K 0.03%
+3,141
New +$183K
NTUS
977
DELISTED
Natus Medical Inc
NTUS
$204K 0.03%
10,177
-6,166
-38% -$121K
CVLG icon
978
Covenant Logistics
CVLG
$872M
$203K 0.03%
+27,386
New +$230K
PIXY
979
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
$203K 0.03%
2
+1
+100% +$90.7K
AVGR
980
DELISTED
Avinger, Inc. Common Stock
AVGR
$203K 0.03%
+1,535
New +$139K
AMED
981
DELISTED
Amedisys
AMED
$202K 0.03%
690
-814
-54% -$209K
BE icon
982
Bloom Energy
BE
$64.6B
$202K 0.03%
+7,032
New +$150K
CNMD icon
983
CONMED
CNMD
$1.47B
$202K 0.03%
+1,801
New +$171K
CUBI icon
984
Customers Bancorp
CUBI
$2.77B
$202K 0.03%
+11,123
New +$176K
DBI icon
985
Designer Brands
DBI
$333M
$202K 0.03%
26,419
-163,397
-86% -$1.09M
IVV icon
986
iShares Core S&P 500 ETF
IVV
$904B
$202K 0.03%
+539
New +$192K
SHW icon
987
Sherwin-Williams
SHW
$89.8B
$202K 0.03%
825
-1,221
-60% -$290K
VOD icon
988
Vodafone
VOD
$37.4B
$202K 0.03%
+12,279
New +$192K
AER icon
989
AerCap
AER
$23.8B
$201K 0.03%
4,400
-10,628
-71% -$371K
OLP
990
One Liberty Properties
OLP
$527M
$201K 0.03%
+10,008
New +$179K
SP
991
DELISTED
SP Plus Corporation
SP
$201K 0.03%
6,956
-12,328
-64% -$303K
CTAS icon
992
Cintas
CTAS
$81.3B
$200K 0.03%
2,268
-5,320
-70% -$462K
FRST icon
993
Primis Financial Corp
FRST
$404M
$200K 0.03%
+16,535
New +$179K
PRQR icon
994
ProQR Therapeutics
PRQR
$265M
$200K 0.03%
+47,625
New +$201K
CARM
995
DELISTED
Carisma Therapeutics
CARM
$199K 0.03%
7,373
+6,509
+753% +$165K
HIMX
996
Himax Technologies
HIMX
$2.55B
$199K 0.03%
26,927
+8,731
+48% +$44.6K
CAMP
997
DELISTED
CalAmp Corp.
CAMP
$196K 0.03%
+859
New +$173K
TTOO
998
DELISTED
T2 Biosystems, Inc
TTOO
$196K 0.03%
+32
New +$196K
HEPA
999
DELISTED
Hepion Pharmaceuticals
HEPA
$195K 0.03%
+89
New +$231K
ENDP
1000
DELISTED
Endo International plc
ENDP
$194K 0.03%
+26,957
New +$141K

Similar funds

GSA Capital Partners's Q4 2020 Portfolio in Review

As of Q4 2020, GSA Capital Partners held 1,794 positions worth $611M, up 2% from $600M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

GSA Capital Partners withdrew a net $91.9M in Q4 2020, closing 643 positions and reducing 313 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $10.9M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

Against the trend, GSA Capital Partners opened a new position in Best Buy worth $2.49M.

  • GSA Capital Partners's largest Q4 2020 buy was Best Buy: 24,945 shares worth $2.49M.
  • GSA Capital Partners added most to Advanced Micro Devices in Q4 2020, an estimated $2.7M increase.
  • GSA Capital Partners's biggest Q4 2020 reduction was BridgeBio Pharma, cutting an estimated $3.35M.
  • GSA Capital Partners fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2020, selling an estimated $10.9M.
  • GSA Capital Partners's ten largest holdings make up 4.8% of its $611M portfolio in Q4 2020.
  • GSA Capital Partners opened 573 new positions and closed 643 in Q4 2020.
  • GSA Capital Partners's portfolio value rose 2% quarter-over-quarter to $611M.

Based on GSA Capital Partners's 13F filing for Q4 2020, filed 3 Feb 2021.